Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert E Becker

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
CNS & Neurological Disorders Drug Targets|January 9, 2009
Alzheimer's disease drug development: old problems require new prioritiesRobert E Becker, Nigel H Greig
Journal of Clinical Psychopharmacology|January 15, 2009
Neuropsychiatric clinical trials: should they accommodate real-world practices or set standards for clinical practices?Robert E Becker, Nigel H Greig
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 3, 2012
Fire in the ashes: can failed Alzheimer's disease drugs succeed with second chances?Robert E Becker, Nigel H Greig
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 16, 2017
Does traumatic brain injury hold the key to the Alzheimer's disease puzzle?Robert E Becker, Dimitrios Kapogiannis, Nigel H Greig
Journal of Alzheimer'S Disease : JAD|October 28, 2008
Why do so many drugs for Alzheimer's disease fail in development? Time for new methods and new practices?Robert E Becker, Nigel H Greig, Ezio Giacobini
Handbook of Clinical Neurology|November 23, 2019
Geriatric pharmacotherapy: Appraising new drugs for neurologic disorders in older patientsMary V Seeman, Robert E Becker, Nigel H Greig
Current Alzheimer Research|February 10, 2009
Resurrecting clinical pharmacology as a context for Alzheimer disease drug developmentRobert E Becker, Latha K Unni, Nigel H Greig
Journal of Pediatric Gastroenterology and Nutrition|April 1, 2024
Esophageal food impaction complicated by bolus adherence and mucosal denudementRobert E Becker, Diana G Lerner, Katherine Vaidy, et al.
Annals of Neurology|August 23, 2014
Amyloid-β precursor protein synthesis inhibitors for Alzheimer's disease treatmentNigel H Greig, Kumar Sambamurti, Debomoy K Lahiri, et al.
The Lancet. Psychiatry|August 8, 2015
What can triumphs and tribulations from drug research in Alzheimer's disease tell us about the development of psychotropic drugs in general?Robert E Becker, Mary V Seeman, Nigel H Greig, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
CNS & Neurological Disorders Drug Targets|January 9, 2009
Alzheimer's disease drug development: old problems require new prioritiesRobert E Becker, Nigel H Greig
Journal of Clinical Psychopharmacology|January 15, 2009
Neuropsychiatric clinical trials: should they accommodate real-world practices or set standards for clinical practices?Robert E Becker, Nigel H Greig
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 3, 2012
Fire in the ashes: can failed Alzheimer's disease drugs succeed with second chances?Robert E Becker, Nigel H Greig
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 16, 2017
Does traumatic brain injury hold the key to the Alzheimer's disease puzzle?Robert E Becker, Dimitrios Kapogiannis, Nigel H Greig
Journal of Alzheimer'S Disease : JAD|October 28, 2008
Why do so many drugs for Alzheimer's disease fail in development? Time for new methods and new practices?Robert E Becker, Nigel H Greig, Ezio Giacobini
Handbook of Clinical Neurology|November 23, 2019
Geriatric pharmacotherapy: Appraising new drugs for neurologic disorders in older patientsMary V Seeman, Robert E Becker, Nigel H Greig
Current Alzheimer Research|February 10, 2009
Resurrecting clinical pharmacology as a context for Alzheimer disease drug developmentRobert E Becker, Latha K Unni, Nigel H Greig
Journal of Pediatric Gastroenterology and Nutrition|April 1, 2024
Esophageal food impaction complicated by bolus adherence and mucosal denudementRobert E Becker, Diana G Lerner, Katherine Vaidy, et al.
Annals of Neurology|August 23, 2014
Amyloid-β precursor protein synthesis inhibitors for Alzheimer's disease treatmentNigel H Greig, Kumar Sambamurti, Debomoy K Lahiri, et al.
The Lancet. Psychiatry|August 8, 2015
What can triumphs and tribulations from drug research in Alzheimer's disease tell us about the development of psychotropic drugs in general?Robert E Becker, Mary V Seeman, Nigel H Greig, et al.
Pageof 5